홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 8-fluoro-5-{[4-[4-(1-methylethyl)-1-piperazinyl]-2-(methyloxy)phenyl]amino}-3-[(4-methylphenyl)sulfonyl]pyrrolo [2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-one

HRID 1014429
인쇄

반응식

HRID 1014429 반응식
Cl[C:2]1[N:3]=[C:4]([NH:21][C:22]2[CH:30]=[CH:29][CH:28]=[C:27]([F:31])[C:23]=2[C:24](N)=[O:25])[C:5]2[CH:10]=[CH:9][N:8]([S:11]([C:14]3[CH:19]=[CH:18][C:17]([CH3:20])=[CH:16][CH:15]=3)(=[O:13])=[O:12])[C:6]=2[N:7]=1.[CH3:32][CH:33]([N:35]1[CH2:40][CH2:39][N:38]([C:41]2[CH:46]=[CH:45][C:44]([NH2:47])=[C:43]([O:48][CH3:49])[CH:42]=2)[CH2:37][CH2:36]1)[CH3:34].[I-].[K+].Cl>C(O)C(F)(F)F.O1CCOCC1.C(=O)(O)[O-].[Na+].C(Cl)Cl>[F:31][C:27]1[CH:28]=[CH:29][CH:30]=[C:22]2[C:23]=1[C:24](=[O:25])[N:3]1[C:2]([NH:47][C:44]3[CH:45]=[CH:46][C:41]([N:38]4[CH2:39][CH2:40][N:35]([CH:33]([CH3:32])[CH3:34])[CH2:36][CH2:37]4)=[CH:42][C:43]=3[O:48][CH3:49])=[N:7][C:6]3[N:8]([S:11]([C:14]4[CH:19]=[CH:18][C:17]([CH3:20])=[CH:16][CH:15]=4)(=[O:13])=[O:12])[CH:9]=[CH:10][C:5]=3[C:4]1=[N:21]2
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 313Hydrochloric Acid2회HCID 4875Potassium Iodide2회HCID 457907394-(4-Isopropylpiperazin-1-YL)-2-methoxyphenylamineHCID 866441882-({2-chloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide

생성물 1

HCID 67316462
8-fluoro-5-{[4-[4-(1-methylethyl)-1-piperazinyl]-2-(methyloxy)phenyl]amino}-3-[(4-methylphenyl)sulfonyl]pyrrolo [2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-one
수율 99%

시약·촉매·용매 3

HCID 64092,2,2-Trifluoroethanol용매HCID 312751,4-Dioxane용매2회HCID 23716255Sodium bicarbonate methylene chloride용매

반응 조건

온도
80 °C

실험 절차

To a solution of 2-({2-chloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide (5.50 g, 11.98 mmol), [4-[4-(1-methylethyl)-1-piperazinyl]-2-(methyloxy)phenyl]amine (4.5 g, 18 mmol, 1.50 equiv.), and potassium iodide (<20 mg) in trifluoroethanol (200 mL) in a 300 mL sealed tube was added hydrochloric acid as a 4.0M solution in dioxane (12 mL, 48 mmol, 4 equiv.). The vessel was sealed and the resulting suspension was stirred rapidly at 80° C. for 12 hours. TLC/LCMS analysis indicates starting material still remains, so additional hydrochloric acid (5 mL as a 4.0M solution in dioxane) and potassium iodide (<20 mg) were added and heating was continued. Three such reactions were cooled and poured directly in saturated sodium bicarbonate/methylene chloride. The organic layer was collected, concentrated under reduced pressure, and then resuspended in diethylether. Sonication for 10 minutes was followed by filtration to give crude 8-fluoro-5-{[4-[4-(1-methylethyl)-1-piperazinyl]-2-(methyloxy)phenyl]amino}-3-[(4-methylphenyl)sulfonyl]pyrrolo[2′,3′:4,5]pyrimido[6,1-b]quinazolin-7(3H)-one as an orange solid with sufficient purity for use in the next transformation (23.5 g, ca 99% yield, purity 85-90%). ESIMS (M+H)+=655.

후처리

  1. customThe vessel was sealed
  2. temperatureheating
  3. temperatureThree such reactions were cooled
  4. customThe organic layer was collected
  5. concentrationconcentrated under reduced pressure
  6. customSonication for 10 minutes
  7. filtrationwas followed by filtration

출처 및 근거

ORD 기록
ord-028c602b3b3147b2920f8f3e11a5d6ed
출처 데이터셋
uspto-grants-2011_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07981903B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트